Data / Drug companies / Clarithromycin
Clarithromycin: 27 companies and 54 products in the FDA NDC directory
Clarithromycin is listed in the FDA National Drug Code Directory by 27 companies, with 54 products in commercial distribution. 54 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet; tablet, film coated, extended release, and the newest product started marketing on March 4, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 27
- Products
- 54
- Generic (ANDA) products
- 54 (100.0%)
- Application numbers
- 9
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list clarithromycin
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 4 | tablet, film coated; tablet | Generic drugs (ANDA) | July 25, 2012 |
| PD-Rx Pharmaceuticals, Inc. | 4 | tablet, film coated; tablet, film coated, extended release | Generic drugs (ANDA) | November 23, 2019 |
| Sandoz Inc | 4 | tablet; for suspension | Generic drugs (ANDA) | September 4, 2007 |
| Sportpharm LLC | 4 | tablet, film coated | Generic drugs (ANDA) | February 1, 2022 |
| Chartwell RX, LLC | 3 | tablet, film coated; tablet, film coated, extended release | Generic drugs (ANDA) | September 10, 2019 |
| Lannett Company, Inc. | 3 | tablet, film coated; tablet, film coated, extended release | Generic drugs (ANDA) | November 23, 2019 |
| Solaris Pharma Corporation | 3 | tablet, film coated; tablet, film coated, extended release | Generic drugs (ANDA) | November 23, 2019 |
| Alembic Pharmaceuticals Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | February 1, 2022 |
| Alembic Pharmaceuticals Limited | 2 | tablet, film coated | Generic drugs (ANDA) | February 1, 2022 |
| Aurobindo Pharma Limited | 2 | tablet, film coated | Generic drugs (ANDA) | July 25, 2012 |
| AvPAK | 2 | tablet, film coated | Generic drugs (ANDA) | October 10, 2016 |
| Bryant Ranch Prepack | 2 | tablet, film coated; tablet | Generic drugs (ANDA) | July 25, 2012 |
| Direct_Rx | 2 | tablet, film coated; tablet | Generic drugs (ANDA) | August 5, 2025 |
| Proficient Rx LP | 2 | tablet, film coated | Generic drugs (ANDA) | December 4, 2015 |
| Proficient Rx LP | 2 | tablet; tablet, film coated | Generic drugs (ANDA) | July 25, 2012 |
| Rising Pharma Holdings, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | July 25, 2012 |
| Actavis Pharma, Inc. | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | February 27, 2014 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | January 29, 2020 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | March 4, 2026 |
| Asclemed USA, Inc. | 1 | tablet | Generic drugs (ANDA) | August 25, 2005 |
| Coupler LLC | 1 | tablet | Generic drugs (ANDA) | February 5, 2025 |
| Major Pharmaceuticals | 1 | tablet, film coated | Generic drugs (ANDA) | July 25, 2012 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | April 3, 2023 |
| Northwind Health Company, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | August 13, 2025 |
| NuCare Pharmaceuticals,Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | July 25, 2012 |
| Preferred Pharmaceuticals Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | July 13, 2023 |
| Remedyrepack Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | February 7, 2017 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 36 | 66.7% |
| Tablet | 10 | 18.5% |
| Tablet, film coated, extended release | 5 | 9.3% |
| For suspension | 3 | 5.6% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 54 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Macrolide Antimicrobial | 54 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.